ZIMMER BIOMET HOLDINGS INC (ZBH) Stock News
NYSE:ZBH - New York Stock Exchange, Inc. - US98956P1021 - Common Stock - Currency: USD
ZBH Latest News, Press Relases and Analysis
Uncover the latest developments among S&P500 stocks in today's session.
Stay informed about the performance of the S&P500 index one hour before the close of the markets on Tuesday. Uncover the top gainers and losers in today's session for valuable insights.
Which S&P500 stocks are moving on Tuesday?
Stay informed about the performance of the S&P500 index in the middle of the day on Tuesday. Uncover the top gainers and losers in today's session for valuable insights.
3 Healthcare Stocks Facing Headwinds
From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. But speed bumps such as inventory destockings have persisted in the wake of COVID-19, and over the past six months, the industry has pulled back by 12.7%. This drop was worse than the S&P 500’s 7.5% loss.
2 Self-Made Millionaires Reveal the First Jobs That Paved the Way to Riches
Ever wonder where today's self-made millionaires got their start? It's easy to imagine everyone with wealth was born that way, but sometimes it comes down to raw talent and serious focus. Learn More:...
Zimmer Biomet to Report Q1 Earnings: Here's What to Expect
ZBH's Hips business is expected to have witnessed growth on the back of its suite of navigation solutions in direct anterior stems and surgical impactors.
Zimmer acquires Paragon 28 in $1.2bn deal
Leveraging Paragon 28's technology platform, Zimmer enhances its portfolios of fracture and trauma, and joint replacement.
Mentions: FNA
What's going on in today's session: S&P500 gap up and gap down stocks
Let's take a look at the S&P500 stocks that are experiencing notable price gaps in today's session on Tuesday. Discover the gap up and gap down stocks in the S&P500 index.
Zimmer Biomet (ZBH): Buy, Sell, or Hold Post Q4 Earnings?
Zimmer Biomet has been treading water for the past six months, recording a small loss of 1.6% while holding steady at $101.84. However, the stock is beating the S&P 500’s 9.8% decline during that period.
Mentions: TTD
Zimmer Biomet Receives CE Mark Approval for RibFix Advantage® Fixation System
/PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE: ZBH and SIX: ZBH), a global medical technology leader, today announced its RibFix Advantage® Fixation...
How Tariffs Are Rocking The 'Bubblegum And Shoestring' Medical Supply Chain
Uncertainty has cast a pall over medical stocks, which are taking a "wait-and-see" approach to Trump's tariffs.
ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Paragon 28, Inc.
/PRNewswire/ -- Rowley Law PLLC is investigating potential securities law violations by Paragon 28, Inc. (NYSE: FNA) and its board of directors concerning the...
Mentions: FNA